GlassScriptPhysician profile
Ramon L Lloret
NPI 1760497507
$31,676.63
in general payments reported to CMS, 2019-2025
42 companies · $1,655 in 2025
The $1,655 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,149 · 2020: $630 · 2021: $3,864 · 2022: $19K · 2023: $2,089 · 2024: $2,548 · 2025: $1,655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,275 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,275.03 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17,254.54 | 2021-2025 | Verquvo |
| Boston Scientific Corporation | $3,821.26 | 2019-2025 | Watchman Flx, Rotablator Rotational Atherectomy System Console Kit |
| Zoll Circulation INC | $3,096.12 | 2021 | |
| Medtronic, INC. | $2,260.73 | 2021-2025 | Cobalt Dr Mri Surescan, Symplicity G3, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $985.32 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $403.88 | 2020-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $337.78 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $273.54 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $269.23 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $232.29 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $231.80 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $216.74 | 2023-2024 | Optimizer, Optimizer |
| Abbott Laboratories | $214.77 | 2019-2025 | Navitor |
| Novartis Pharmaceuticals Corporation | $211.11 | 2019-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $181.75 | 2024 | Arcalyst |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Lloret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.